Help us: Donate
Follow us on:
×

Menu

Back

Tag: Drug Discovery

Unexpected treasure
Researchers have found that zoledronate, a drug used to treat osteoporosis, has unexpected life-extending properties in human beings, and they confirmed these findings in a fruit fly study. The original unexpected findings Zoledronate is a biophosphonate, a drug used to strengthen bones and reduce the risk of osteoporosis-related bone fractures. It is well-absorbed into the...
Quantum computer
With a new announcement from IBM and Germany’s Fraunhofer Institute, the era of quantum computing has finally arrived in Europe. Can its advance speed up the discovery of new drugs? Europe joins the race Despite being a research and manufacturing powerhouse, Germany, like Europe as a whole, has been lagging behind in what is probably...
Deep Longevity
Today, we have a bit more positive news with the announcement that Deep Longevity has added LifeHub and LifeClinic to its network of longevity-focused companies. This company plans to use multiple AI-based biological aging clocks to test a variety of longevity interventions, including supplements, drugs, and lifestyle choices. Teaming up to offer longevity healthcare This...
Dr. João Pedro de Magalhães is a Professor at the University of Liverpool, England, where he studies aging and longevity at the genetic level, and he is also an affiliate Principal Investigator in the Neuroendocrinology and Aging Group at the University of Coimbra, Portugal. Dr. de Magalhães has built the Human Ageing Genomic Resources (HAGR),...
Pills
A bold feature article published in Drug Discovery Today illustrates the coming of age of longevity pharmacology. Dr. João Pedro de Magalhães, one of the biggest names in longevity research, outlined some of the great strides taken in the last two decades, as various discoveries have been made in the biology of aging. Lifespan has...
Joao Pedro de Magalhaes at EARD2019
This is the final talk that we are releasing from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. João Pedro de Magalhães of the University of Liverpool discussed the genetic basis of aging and...